305 related articles for article (PubMed ID: 15224177)
1. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus].
Stangel M; Gold R
Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177
[TBL] [Abstract][Full Text] [Related]
2. [The rational immunotherapy with intravenous immunoglobulin in neurologic diseases].
Korsak J
Pol Merkur Lekarski; 2011 Jun; 30(180):430-4. PubMed ID: 21751554
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin use for neurologic diseases.
Koski CL; Patterson JV
J Infus Nurs; 2006; 29(3 Suppl):S21-8. PubMed ID: 16878852
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of intravenous immunoglobulins in neurology.
Hughes RA; Dalakas MC; Cornblath DR; Latov N; Weksler ME; Relkin N
Clin Exp Immunol; 2009 Dec; 158 Suppl 1(Suppl 1):34-42. PubMed ID: 19883422
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
[TBL] [Abstract][Full Text] [Related]
6. [Current use of immunoglobulins in neurology].
Cursiefen S; Mäurer M
Nervenarzt; 2008 Sep; 79 Suppl 2():67-74; quiz 75-6. PubMed ID: 18679643
[TBL] [Abstract][Full Text] [Related]
7. EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.
Elovaara I; Apostolski S; van Doorn P; Gilhus NE; Hietaharju A; Honkaniemi J; van Schaik IN; Scolding N; Soelberg Sørensen P; Udd B;
Eur J Neurol; 2008 Sep; 15(9):893-908. PubMed ID: 18796075
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.
Lünemann JD; Nimmerjahn F; Dalakas MC
Nat Rev Neurol; 2015 Feb; 11(2):80-9. PubMed ID: 25561275
[TBL] [Abstract][Full Text] [Related]
9. Evidence-based guideline: intravenous immunoglobulin in the treatment of neuromuscular disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Patwa HS; Chaudhry V; Katzberg H; Rae-Grant AD; So YT
Neurology; 2012 Mar; 78(13):1009-15. PubMed ID: 22454268
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin in autoimmune neuromuscular diseases.
Dalakas MC
JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209
[TBL] [Abstract][Full Text] [Related]
11. IVIG therapy in neurological disorders of childhood.
Archelos JJ; Fazekas F
J Neurol; 2006 Sep; 253 Suppl 5():V80-6. PubMed ID: 16998760
[TBL] [Abstract][Full Text] [Related]
12. Clinical Applications of Intravenous Immunoglobulins in Child Neurology.
Gogou M; Papadopoulou-Alataki E; Spilioti M; Alataki S; Evangeliou A
Curr Pharm Biotechnol; 2017 Nov; 18(8):628-637. PubMed ID: 28914199
[TBL] [Abstract][Full Text] [Related]
13. Guidelines on the use of intravenous immune globulin for neurologic conditions.
Feasby T; Banwell B; Benstead T; Bril V; Brouwers M; Freedman M; Hahn A; Hume H; Freedman J; Pi D; Wadsworth L
Transfus Med Rev; 2007 Apr; 21(2 Suppl 1):S57-107. PubMed ID: 17397768
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
Bembeeva RT; Zavadenko NN
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):83-93. PubMed ID: 26356621
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Lünemann JD; Quast I; Dalakas MC
Neurotherapeutics; 2016 Jan; 13(1):34-46. PubMed ID: 26400261
[TBL] [Abstract][Full Text] [Related]
16. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology?
Elovaara I; Hietaharju A
Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin Treatment in Neuromuscular Medicine.
Burakgazi AZ
J Clin Neuromuscul Dis; 2019 Jun; 20(4):182-193. PubMed ID: 31135621
[TBL] [Abstract][Full Text] [Related]
18. Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects.
Dalakas MC
J Neurol; 2006 Sep; 253 Suppl 5():V25-32. PubMed ID: 16998751
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin treatment of neurological autoimmune diseases.
Stangel M; Hartung HP; Marx P; Gold R
J Neurol Sci; 1998 Jan; 153(2):203-14. PubMed ID: 9511879
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome.
Buchwald B; Ahangari R; Weishaupt A; Toyka KV
Ann Neurol; 2002 Jun; 51(6):673-80. PubMed ID: 12112071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
